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The Type VI secretion system (T6SS) is a multiprotein weapon used by bacteria to 17 
destroy competitor cells. The T6SS contractile sheath wraps an effector-loaded syringe 18 
that is injected into the target cell. This tail structure assembles onto the baseplate that 19 
is docked to the membrane complex. In entero-aggregative Escherichia coli TssA plays a 20 
central role at each stage of the T6SS assembly pathway by stabilizing the baseplate and 21 
coordinating the polymerization of the tail. Here we adapted an assay based on APEX2-22 
dependent biotinylation to identify the proximity partners of TssA in vivo. By using 23 
stage-blocking mutations, we define the temporal contacts of TssA during T6SS 24 
biogenesis. This proteomic mapping approach also revealed an additional partner of 25 
TssA, TagA. We show that TagA is a cytosolic protein tightly associated with the 26 
membrane. Analyses of sheath dynamics further demonstrate that TagA captures the 27 
distal end of the sheath to stop its polymerization and to maintain it under the extended 28 
conformation. 29 
The bacterial Type VI secretion system (T6SS) is a tail structure that uses a contractile 30 
mechanism to inject a molecular syringe loaded with effectors into target cells1-8. This 31 
sophisticated apparatus is widespread in Gram-negative bacteria, and could be deployed to 32 
deliver effectors to the milieu, or into eukaryotic host cells or competitor bacterial cells. The 33 
T6SS helps to establish symbiosis, to collect metals or to disable or kill target cells5,9-13. At 34 
the molecular level, the T6SS requires a minimum set of 12 proteins that are indispensable for 35 
its assembly and function whereas additional, accessory proteins such as peptidoglycan-36 
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binding proteins, peptidoglycan remodelling enzymes, disassembly ATPases and spike 37 
sharpeners might be necessary to improve its efficiency4,6,15-17. 38 
The assembly of the T6SS is a coordinated process in which each subunit is recruited 39 
in a definite order. The TssA protein is required at each stage of T6SS biogenesis and 40 
mediates specific contacts with each of the T6SS sub-complexes18. In entero-aggregative E. 41 
coli (EAEC), the outer membrane lipoprotein TssJ positions first and recruits the inner 42 
membrane proteins TssM and TssL19-21. Polymerization of the TssJLM heterotrimer into a 43 
1.7-MDa trans-envelope channel, named membrane complex, comprising 10 copies of each 44 
protein, occurs after local remodelling of the cell wall which is assured by a transglycosylase 45 
that is recruited to and activated by TssM21,22. Binding of the TssA protein onto the 46 
membrane complex recruits and stabilizes a second multi-protein complex, the baseplate18. 47 
The baseplate comprises five different proteins: TssE, –F, –G, –K and VgrG23-26. The 48 
baseplate constitutes the assembly platform for the tail and shares structural and functional 49 
homologies with the baseplates of other contractile structures such as bacteriophages25,26. The 50 
T6SS baseplate is a mosaic structure that groups subunits evolutionarily related to the 51 
minimal myophage baseplate (TssE, –F and –G are homologues of the Mu phage Mup46, 52 
Mup47 and Mup48 proteins respectively, whereas VgrG is a fusion protein between 53 
homologues of Mup44 and Mup45), and TssK, a protein related to siphophage receptor-54 
binding proteins that has evolved a C-terminal domain that anchors the baseplate to the 55 
membrane complex25-30. Once the baseplate is docked to the membrane complex23,25,31,32, the 56 
tail is built by the processive addition of inner tube and contractile sheath building blocks3,33-57 
35. Tail assembly is a coordinated process, in which tube and sheath polymerizations are 58 
interdependent but it has been proposed that the assembly of one tube hexamer immediatly 59 
precedes the polymerization of one sheath row18,33. The coordinated assembly of the sheath 60 
with that of the tube is dictated by the TssA subunit18,36. During the assembly process, TssA 61 
remains at the distal end of the tail, at which new subunits are incorporated18,37. Fluorescence 62 
microscopy recordings revealed that the length of the tail is not controlled but rather that its 63 
polymerization stops once the distal end is at proximity of the membrane1,2,18,25. Once the 64 
biogenesis of the tail is completed, TssA remains associated to the distal end, and it has been 65 
proposed that TssA remains until the last row of sheath contracts18,36. However, the molecular 66 
mechanism that controls the arrest of sheath polymerization and how the sheath is maintained 67 
in the extended conformation for long periods of time are not known.  68 
 69 
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APEX2-dependent labeling of TssA proximity partners. 70 
Because TssA is located at the distal end of the sheath, we reasoned that definition of 71 
the TssA interactome may provide insights onto the late stages of T6SS assembly. To identify 72 
TssA partners in living cells, we developed a spatially resolved proteomic-mapping assay 73 
based on proximity-dependent biotinylation. APEX2-dependent biotinylation is a recent 74 
technology used in eukaryotic cells to define protein sub-cellular localization, membrane 75 
protein topology or protein partners38,39. APEX2 is an engineered variant of the monomeric 76 
ascorbate peroxidase that oxidizes phenol derivatives to phenoxyl radicals in presence of 77 
hydrogen peroxyde (H2O2)38. Hence APEX2 converts biotin-phenol to short-lived, small-78 
distance diffusive biotin-phenoxyl radicals that covalently react with electron-rich amino-acid 79 
side chains. Based on biotin-phenoxyl radicals half-life and diffusion rates, it is proposed that 80 
APEX2 biotinylates macromolecules located within 20 nm radius40. Once fused to a bait 81 
protein, APEX2 labels proteins present within the diffusion radius, and hence proteins in 82 
contact with the bait and proteins that share the same space. These proximity-biotinylated 83 
proteins can be then enriched on streptavidin and identified by mass spectrometry. In the 84 
recent years, this approach has been successfully employed to define the mitochondrial matrix 85 
proteome, to identify partners of G-protein coupled receptors and to map the Chlamydia 86 
trachomatis inclusion membrane39-46. However, studies have been restricted to eukaryotic 87 
cells and no example of APEX2-dependent labeling is yet available inside bacterial cells. We 88 
engineered a pKD4 vector derivative, pKD4-APEX2 (Supplementary Fig. 1a), allowing 89 
insertion of the apex2 sequence at the locus of interest on the bacterial genome using the one-90 
step procedure47. The apex2-coding sequence was genetically fused to tssA (gene accession 91 
number GI:284924261), at the native chromosomal locus in the EAEC genome to generate a 92 
APEX2-TssA fusion protein (Supplementary Fig. 1b). APEX2 was fused at the N-terminus of 93 
TssA, as we previously showed that the presence of GFP at this position did not prevent T6SS 94 
activity18. Indeed, anti-bacterial competition assay showed that cells producing APEX2-TssA 95 
eliminate competitor E. coli K-12 cells at a level comparable to the wild-type strain, 96 
demonstrating that fusion of APEX2 at the N-terminus of TssA does not impact T6SS activity 97 
(Supplementary Fig. 1c). Western-blot analyses of lysates of wild-type cells producing 98 
APEX2-TssA using a streptavidin-coupled antibody showed that several proteins are 99 
specifically biotinylated in presence of biotin-phenol and H2O2, demonstrating that APEX2 is 100 
functional in the bacterial cytoplasm (Supplementary Fig. 1d).  101 
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Wild-type cells producing the chromosomal APEX2-TssA fusion were mixed with E. 102 
coli K-12 competitor cells and incubated on plates containing 10 mM biotin-phenol. This 103 
concentration of biotin-phenol does not impact bacterial growth (Supplementary Fig. 2a) nor 104 
T6SS activity (Supplementary Fig. 2b). Live cells were then treated for 1 min with H2O2 and 105 
biotinylated TssA proximity partners were enriched on streptavidin beads after quenching and 106 
cell lysis. The total eluate was subjected to mass spectrometry for protein identification (Table 107 
1, first column). The highest hits correspond to T6SS subunits, including the TssM and TssL 108 
membrane proteins, the TssK, VgrG, TssF and TssG baseplate components, the Hcp and TssC 109 
tail proteins, as well as a protein of unknown function, encoded by the EC042_4550 gene 110 
(accession number GI: 284924271; hereafter named TagA). Interestingly, TssK, VgrG, Hcp 111 
and TssC are known interacting partners of TssA18 whereas TssF and TssG form a stable 112 
complex with TssK24,25 and are likely at close proximity to the TssK-bound TssA. Finally, 113 
while no direct contacts have been identified between TssA and TssM and TssL, the TssA 114 
protein was previously shown to co-purify with the TssJLM complex18. The EC042_4550 115 
gene, located at close proximity to the T6SS core component genes (Supplementary Fig. 1b), 116 
encodes a protein of the TssA family, which shares the N-terminal ImpA domain but has a 117 
different C-terminal extension and was thus named TagA (Type VI accessory gene with 118 
ImpA domain)36. The two T6SS integral inner membrane proteins, TssM and TssL, were not 119 
retrieved when detergent was omitted during preparation of the lysate sample prior to 120 
streptavidin enrichment (Table 1, second column). No significant hits were recovered from 121 
mass spectrometry analysis of streptavidin-enriched samples from wild-type cells that do not 122 
produce APEX2-TssA (Table 1, third column). In addition, no T6SS proteins were 123 
biotinylated when APEX2 was produced from the tssA locus but not fused to TssA (Table 1, 124 
fourth column). Finally, we generated a EAEC strain producing a fusion between APEX2 and 125 
GspE, a cytosolic ATPase that transiently associates with the membrane-anchored Type II 126 
secretion system (T2SS)48. Although two known T2SS partners of GspE, GspF and GspL49, 127 
were labeled, none of the T6SS subunit was recovered in the enriched fraction (Table 1, fifth 128 
column). All these controls experiments demonstrate the specificity of APEX2 labeling when 129 
fused to TssA. 130 
 131 
Stage-specific blocking mutations define the temporal TssA contacts during T6SS 132 
biogenesis. 133 
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Previous data have suggested that TssA mediates sequential contacts with the 134 
membrane complex, the baseplate and the tail, during T6SS biogenesis18,36. We sought to test 135 
this model by arresting T6SS assembly at each stage, using non-polar mutants we previously 136 
generated. In absence of TssL, the membrane complex does not assemble and T6SS assembly 137 
is blocked at an early stage21. Indeed, no significant hit was recovered in a tssL strain (Table 138 
2; first column). The observation that both TssM and TssL are biotinylated in tssK and vgrG 139 
cells (Table 2, second and third columns) is in agreement with the fact that the membrane 140 
complex is assembled in absence of baseplate components25 and with the proposal that TssA 141 
is bound at the cytosolic face of the membrane complex18,36. Finally, the biotinylation of 142 
membrane complex and baseplate components in hcp cells (Table 2, fourth column) correlates 143 
with the obervation that the absence of Hcp prevents polymerization of the tail but does not 144 
impact membrane complex and baseplate assembly25. A schematic summary of proteins 145 
biotinylated by APEX2-TssA during T6SS biogenesis is shown in Figure 1.     146 
 147 
TagA associates at the distal end of the sheath. 148 
The identification of TagA, a protein of unknown function, as a proximity partner of 149 
TssA and the location of the tagA gene at close proximity to T6SS core component genes led 150 
us to further characterize this protein. Interestingly, TagA was not biotinylated in tssL, tssK, 151 
vgrG or hcp cells (Table 2), suggesting that it contacts TssA in the late stage (i.e., tail 152 
polymerization) of T6SS biogenesis. Bacterial two-hybrid and co-immunoprecipitation assays 153 
demonstrated that TagA directly interacts with TssA (Fig. 2a and 2b). Competition assays 154 
further showed that the tagA mutant strain retains 12 ± 4 % of activity (Fig. 2c). Anti-bacterial 155 
activity was restored to wild-type levels upon cis-complementation with wild-type TagA or 156 
VSV-G-tagged TagA (VTagA; Fig. 2c). Hence, TagA is not an essential protein for T6SS 157 
action but rather increases the efficiency of the Type VI apparatus. To gain further insights 158 
into TagA localization, we performed fractionation and fluorescence microscopy experiments. 159 
In EAEC wild-type and ∆sci1 (i.e., a strain deleted of the T6SS gene cluster, from tssB to 160 
tssJ) cells, as well as in E. coli K-12 (devoid of T6SS gene cluster) cells, VTagA co-161 
fractionnates with the EF-Tu cytoplasmic elongation factor and with membrane-associated 162 
proteins such as OmpA, TolA and TolB (Fig. 2d). However, by contrast to OmpA and TolA, 163 
VTagA behaves similarly to the peripherally-associated membrane protein TolB: VTagA is 164 
partly released from the membrane upon urea treatment (Fig. 2d), suggesting that TagA is a 165 
cytosolic protein that associates with the membrane independently of T6SS subunits. In 166 
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agreeement with this conclusion, fluorescence microscopy imaging of a functional TagA 167 
fusion to superfolder GFP (sfGFP-TagA; Supplementary Fig. 3) revealed that TagA 168 
assembles sub-membrane punctate foci (Fig. 3a and 3b). The association of these punctate 169 
foci with the membrane was confirmed by deconvolution analyses (Supplementary Fig. 4a). 170 
Interestingly, these foci are not randomly distributed but rather cluster at the ¼ of the cell (Fig. 171 
3c). Time-lapse recordings in wild-type showed that these foci dynamically associate - or 172 
appear close to the ¼ and ¾ of the cell (Fig. 3d). Interestingly, the formation of static or 173 
dynamic sfGFP-TagA foci is dependent upon the T6SS subunits, as sfGFP-TagA localizes at 174 
diffuse membrane patches in Δsci1 cells (Supplementary Fig. 4b). 175 
To better define the localization of TagA, we performed co-localization studies with a 176 
mCherry-tagged TssB sheath subunit. Fig. 3e shows that TagA localizes at one extremity of 177 
the sheath. Because the sheath extends from the baseplate to the opposite side of the cell, we 178 
next asked whether TagA partitions with the baseplate or locates at the distal end of the sheath. 179 
Co-localization experiments with the TssK baseplate subunit fused to the mCherry defined 180 
that sfGFP-TagA and TssK-mCherry do not co-localize, demonstrating that TagA is not a 181 
component of the baseplate (Fig. 3f and Supplementary Fig. 5). From these results, we 182 
conclude that TagA associates with the distal end of the sheath. This conclusion is in 183 
agreement with the APEX2-TssA-mediated biotinylation of TagA only in cells authorizing 184 
sheath polymerization. To gain further insights into TagA dynamics, we imaged sheath 185 
assembly in cells producing sfGFP-TagA. Examination of full cycles of sheath 186 
extension/contraction (see blue arrow in Fig. 3g) established that TagA is captured by the 187 
distal end of the sheath once it approaches the membrane (Fig. 3g, Supplementary Fig. 5, 188 
Supplementary Video 1).  189 
 190 
TagA stops sheath polymerization and stabilizes the extended sheath conformation. 191 
To determine the role of TagA in sheath dynamics, we imaged wild-type, tagA and 192 
complemented tagA cells producing TssB-sfGFP. Time-lapse fluorescence recordings 193 
revealed some remarkable sheath dynamics in tagA cells: about fifty percent of the sheaths 194 
extend toward the opposite side of the membrane but do not stop, and hence undergo a 195 
distortion event allowing their extension parallel to the membrane (Fig. 4a-b; Supplementary 196 
Video 2), ultimately leading to sheaths break or detachment from the membrane 197 
complex/baseplate (see red arrowheads in Fig. 4a). This observation suggests that in absence 198 
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of TagA, the polymerization of some of the sheaths does not stop at the opposite membrane 199 
(i.e., the location of TagA) and thus that TagA may constitute the stopper – or part of the 200 
stopper –  for T6SS sheath extension. These sheaths are likely to be non-productive, 201 
explaining the decreased T6SS activity in tagA cells. The remaining sheaths undergo usual 202 
extension/contraction cycles. However, we noticed that most of these sheaths contract rapidly 203 
after completion of their extension. Comparison of the residence time of extended sheaths (i.e., 204 
duration of the extended sheath conformation prior to contraction) in wild-type, tagA and 205 
complemented tagA cells revealed that sheaths contract significantly more rapidly after tail 206 
competion in absence of TagA (Fig. 4c, Supplementary Fig. 6). Interestingly, the distribution 207 
of the residence time differs considerably between wild-type and tagA cells: the number of 208 
sheaths that contract immediatly after extension is significantly increased in tagA cells (> 209 
60% of the events) compared to wild-type of complemented tagA cells (∼ 5% of the events) 210 
(Fig. 4c, Supplementary Fig. 6). These results provide support to an additional role of TagA 211 
as a clamp to stabilize the extended sheath and/or to maintain the sheath under the extended 212 
conformation. 213 
 214 
Concluding remarks 215 
In this study we have adapted the APEX2-dependent biotin ligation technology 216 
initially developed in eukaryotic cells to study bacterial complexes. We report the 217 
identification of the in vivo proximity partners of the T6SS-associated TssA protein and use 218 
this approach in stage-specific blocking mutant cells to temporally resolve the TssA contacts 219 
during T6SS biogenesis. We show that TssA successively engages with different complexes: 220 
it interacts first with the inner membrane proteins of the membrane complex (TssL, TssM), 221 
and then the baseplate (TssF, TssG, TssK and VgrG,) and the tail (Hcp, TssC). This powerful 222 
approach recapitulates the known interacting partners of TssA previously identified by 223 
bacterial two-hybrid, co-precipitation and surface-plasmon resonance assays18. This 224 
technology also detected two known partners of the T2SS-associated GspE ATPase, GspF 225 
and GspL49-52. To our knowledge, this is the first report of the use of APEX2-dependent 226 
proximity biotinylation inside living bacterial cells. This approach is specifically powerful to 227 
dissect contacts of a dynamic protein that engages in different complexes during assembly of 228 
a multiprotein system or that is involved in different processes during the cell cycle. 229 
Interestingly, APEX2 fusion to TssA revealed an additional player in Type VI secretion in 230 
EAEC, TagA. TagA could not be considered as a T6SS core component as the tagA gene is 231 
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found associated with a limited number of T6SS gene clusters, including that of Xenorhabdus 232 
and Photorhabdus species as well as Aeromonas hydrophila and Vibrio cholerae36. In 233 
agreement with the phenotypes associated with the deletion of the tagA gene in V. cholerae, 234 
VCA012153, competition experiments provided evidence that TagA is not essential for T6SS 235 
activity in EAEC. However, the presence of TagA optimizes T6SS efficiency as a tagA 236 
mutant retains 12 ± 4 % of anti-bacterial activity compared to the wild-type strain. Domain 237 
analyses of TagA showed that it shares the N-terminal ImpA domain found in proteins of the 238 
TssA family, including EAEC TssA and P. aeruginosa TssA118,36,54, and a C-terminal 239 
extension of unknown function. These two domains are separated by a long linker comprising 240 
a stretch of hydrophobic residues predicted to be arranged as an amphipatic α-helix36. Indeed, 241 
TagA is a cytosolic protein that peripherally but tightly associates with the membrane. 242 
Interestingly, TagA localizes at specific positions in the cell, halfway between midcell and the 243 
cell poles. Although we do not know the cellular determinants that control this specific 244 
positioning, TagA is captured by the distal end of the sheath, likely by directly interacting 245 
with the TssA cap protein. TagA-TssA contacts might be mediated by their N-terminal ImpA 246 
domains, which have been previously shown to dimerize18. It is noteworthy that the tagA gene 247 
is usually present within T6SS gene clusters encoding TssA, but not TssA1. This observation, 248 
the interaction between the TssA and TagA, and the presence of TagA at proximity of TssA 249 
when sheath extension is completed as revealed by the in vivo APEX2 assay, support a 250 
functional relationship between TssA (and the distal extremity of the sheath) and TagA. 251 
Indeed, sfGFP-TagA was shown to present a diffuse membrane pattern in absence of T6SS 252 
subunits and to assemble foci at the site of contact of the distal end of the sheath with the 253 
opposite membrane. The observation that TagA is captured by the distal end of the sheath 254 
suggests a role of this accessory protein during the late stages of sheath assembly. In 255 
agreement with this suggestion, fluorescence microscopy recordings of the T6SS sheath 256 
showed two different consequences of the absence of TagA. First, aberrant sheath 257 
polymerization was observed, in which sheath polymerization does not stop at the membrane, 258 
leading to sheath distortion, bending and, ultimately, breaking. These sheaths do not contract 259 
and hence are unfruitful to destroy rival bacteria, likely explaining the decreased T6SS 260 
activity in tagA cells. The second consequence of the absence of TagA is the rapid contraction 261 
after sheath extension. One explanation to these two distinct events might be how the sheath 262 
hits the membrane. It has been proposed that incorporation of new Hcp hexamers in the 263 
growing tail occurs by opening the central hexaflexagon structure of TssA18,36. Therefore, one 264 
may hypothesize that if the sheath arrives perpendicular to the membrane, there is no room to 265 
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allow incorporation of new Hcp hexamers, hence arresting sheath polymerization. In absence 266 
of TagA, these sheaths will contract rapidly. By contrast, if the sheath does not arrive 267 
perpendicular, new Hcp hexamers can enter the TssA central lumen, allowing the sheath 268 
polymerization to proceed and causing sheath distortion and bending. One alternative 269 
hypothesis is that the absence of TagA is partly compensated by an unknown factor for 270 
preventing uncontroled sheath extension. Using the APEX2 technology to identify proteins at 271 
proximity of TagA may provide further insights into T6SS tail completion. 272 
Based on our results, we propose that TagA associates with the cytoplasmic side of the 273 
inner membrane. Once the distal end of the sheath approaches the opposite membrane, TagA 274 
is captured, stops sheath polymerization and clamps the extended sheath to the membrane. By 275 
linking both the sheath distal extremity and the membrane, TagA prevents the immediate 276 
contraction of the sheath and maintains the tensile forces required for efficient killing. TagA 277 
is thus employed by TssA+ T6SS as a sheath stopper and clamp. 278 
  279 
METHODS 280 
Bacterial strains, media and chemicals 281 
Enteroaggregative E. coli was used as model micro-organism. Escherichia coli K-12 strains DH5α, W3110 and 282 
BTH101 were used for cloning procedures and fractionation, and bacterial two-hybrid assay, respectively. 283 
Enteroaggregative E. coli (EAEC) strains used in this work are isogenic derivatives of the wild-type O3:H2 17-2 284 
strain. E. coli K-12 and EAEC cells were routinely grown in LB broth at 37°C, with aeration. For induction of 285 
the sci1 T6SS gene cluster, cells were grown in Sci1-inducing medium [SIM: M9 minimal medium 286 
supplemented with glycerol (0.2%), vitamin B1 (1 μg.mL−1), casaminoacids (40 μg.mL−1), LB (10% v/v)]55. 287 
Plasmids and chromosomal deletions and insertions were maintained by the addition of ampicillin (100 μg.mL−1 288 
for K-12), kanamycin (50 μg.mL−1 for K-12, 50 μg.mL−1 for chromosomal insertion on EAEC, 100 μg.mL−1 for 289 
plasmid bearing EAEC), or chloramphenicol (40 μg.mL−1). Expression of genes from pBAD or pASK-IBA 290 
vectors was induced at A600 nm ≈ 0.6 with 0.02% of L-arabinose (Sigma-Aldrich) for 1 h or with 0.1 μg.mL-1 of 291 
anhydrotetracyclin (IBA Technologies) for 45 min, respectively. For BACTH experiments, gene expression was 292 
induced by the addition of iso-propyl-β-D-thio-galactopyranoside (IPTG, Sigma-Aldrich, 0.5 mM) and plates 293 
were supplemented with 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-Gal, Eurobio, 40 μg.mL−1). 294 
Strain construction 295 
The tagA gene (EC042_4550) was deleted in the enteroaggregative E. coli 17-2 strain using λ-red 296 
recombination47 as previously described19 using plasmid pKOBEG56. In brief, a kanamycin cassette was 297 
amplified from plasmid pKD4 using oligonucleotides carrying 50-nucleotide extensions homologous to regions 298 
adjacent to tagA. After electroporation of 600 ng of column-purified PCR product, kanamycin-resistant clones 299 
were selected and verified by colony-PCR. The kanamycin cassette was then excised using plasmid pCP2047 and 300 
confirmed by colony-PCR. The same procedure was used to introduce APEX2 on the chromosome. The APEX2-301 
coding sequence was amplified using the pKD4-Nter-APEX2 vector and inserted downstream of the start codon 302 
of the tssA (APEX2-TssA) or gspE (APEX2-GspE) genes or upstream the start codon of tssA (APEX2 in the 303 
T6SS gene cluster). Fluorescent reporter genes were amplified from the pKD4-Nter-sfGFP (N-terminal sfGFP 304 
fusions) or pKD4-Cter-mCherry (C-terminal mCherry fusions) vectors18,25 and inserted on the chromosome 305 
downstream of the start codon of the tagA gene (sfGFP-TagA fusion) or upstream of the stop codon of the tssK 306 
gene (TssK-mCh fusion). For cis-complementation, a pKD4 derivative vector was engineered in which the tagA 307 
gene (or the tagA gene encoding an N-terminally VSV-G-tagged version of tagA) was placed under the control 308 
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of the sci1 T6SS promoter. The cassette was then introduced on the chromosome of the ∆tagA and ∆tagA 309 
tssBsfGFP strains, at the lacZ locus, by λ-red recombination using pKOBEG.  310 
Plasmid construction 311 
PCR was performed using a Biometra thermocycler using the Q5 DNA polymerase (New England Biolabs). 312 
Enteroaggregative E. coli 17-2 chromosomal DNA or the pcDNA3-APEX2-NES plasmid (Addgene #49386)38 313 
were used as template for PCR amplification. All the plasmids have been constructed by restriction-free 314 
cloning57. Primers used in this study are listed in Supplementary Table 1. Briefly, the gene of interest was 315 
amplified using oligonucleotides introducing extensions annealing to the target vector. The double-stranded 316 
product of the first PCR has then been used as oligonucleotides for a second PCR using the target vector as 317 
template. PCR products were then treated with DpnI to eliminate template plasmids.  All constructs have been 318 
verified by PCR and DNA sequencing (Eurofins Genomics). Plasmid pKD4-Nter-APEX2 was deposited in the 319 
Addgene plasmid repository under accession number 112868. 320 
In vivo APEX2-dependent biotin labeling and identification of biotinylated proteins by mass spectrometry 321 
Biotin proximity labeling. Experiments were initially conducted to optimize the conditions of biotin proximity 322 
labeling, by varying the concentration of biotin phenol, the concentration of H2O2, and the duration of the H2O2 323 
pulse. EAEC wild-type and APEX2 derivative cells were mixed with E. coli K-12 competitor cells and spotted 324 
on SIM plates supplemented with 10 mM biotin phenol (Biotine Tyramide; BP, Iris Biotech). After 4 h at 37°C, 325 
cells were washed with 1 mL of SIM medium to eliminate residual BP, and treated with 1 mM hydrogen 326 
peroxide (H2O2; Sigma Aldrich) for 1 min before quenching by washing with TSEN buffer (Tris-HCl 20 mM pH 327 
8, sucrose 30%, EDTA 1 mM, NaCl 100 mM) supplemented with egg-white lysozyme 10 μg.mL−1, 10 mM 328 
sodium ascorbate and 10 mM sodium azide. Cells were either analyzed by SDS-PAGE and Streptavidin western-329 
blotting or lysed by resuspension in CellLyticTM B (Sigma-Aldrich) supplemented or not with 0.2% Igepal® CA-330 
630 (Sigma-Aldrich). After 1 hour on a wheel, lysates were clarified by centrifugation at 20,000×g  for 10 min.  331 
Streptavidin pull-down of biotinylated proteins. The clarified cell lysate was incubated for 30 min at room 332 
temperature with 2 mg of Streptavidin-coated magnetic beads, equilibrated in CellLyticTM B buffer 333 
supplemented with Igepal CA-630. After three washes with CellLyticTM B supplemented with Igepal CA-630, 334 
the beads were resuspended in Laemmli loading dye and loaded on a SDS-PAGE gel. The migration was 335 
stopped when the sample reached the interface between concentrating and separating gels, and the band 336 
containing the total biotinylated proteins was cut out.   337 
Mass spectrometry analyses. The protein-containing SDS-PAGE gel bands were washed with 100 mM 338 
acetonitrile/ammonium bicarbonate pH 7.5, reduced by 10 mM dithiothreitol in 100 mM ammonium bicarbonate 339 
pH 7.5, alkylated by 55 mM iodoacetamide in 100 mM ammonium bicarbonate pH 7.5, and overnight digested 340 
at 37 °C by Trypsin/Lys-C Mix from Pseudomonas aeruginosa (Promega) at 10 ng.µL-1 in 25 mM ammonium 341 
bicarbonate pH 7.5/proteaseMAXTM surfactant 0.025% (v/v). Tryptic peptides were extracted from gels by 0.1% 342 
(vol/vol) trifluoroacetic acid (TFA)/0.01% (vol/vol) proteaseMAXTM/50% (vol/vol) acetonitrile, and dried by 343 
speed vacuum. Solubilized samples in 0.05% (vol/vol) TFA /2 % (vol/vol) acetonitrile were analyzed on a ESI-344 
Q-Exactive Plus (ThermoFisher) mass spectrometer coupled to a nanoliquid chromatography (Ultimate 3000, 345 
Dionex). Peptides were eluted from a C18 column (Acclaim PepMap RSLC, 75 µm × 150 mm, 2 µm, 100 Ǻ, 346 
Dionex) by a 6-40% linear gradient of mobile phase B (0.1% (vol/vol) formic acid (FA)/80% (vol/vol) 347 
acetonitrile) in mobile phase A (0.1% (vol/vol) FA) for 52 min. The peptides were detected in the mass 348 
spectrometer in a positive ion mode using a Top 10 Data Dependent workflow. One scan event full MS in the 349 
Orbitrap at 70,000, in a 350-1900 m/z range was followed by a fragmentation MS/MS step, at 17,500, of the 10 350 
top ions, in the Higher Energy Collisional Dissociation cell set at 27. The spectra were processed by Proteome 351 
Discoverer software (ThermoFisher, version: 2.1.0.81) using the Sequest HT algorithm with the search following 352 
parameters: enteroaggregative E. coli 042 database (Taxonomy ID 216592 downloaded from NCBI by Protein 353 
Center, 4921 entries); trypsin enzyme (maximum 2 missed cleavages); fixed modification: carbamidomethyl 354 
(Cys); variable modification: oxidation (Met); mass values specific for monoisotopic; precursor mass tolerance: 355 
± 10 ppm; fragment mass tolerance: ± 0.02 Da. Peptide validation was based on the best Peptide Spectrum 356 
Match (PSM) defined at a 0.05 maximum Delta Cn and a 0.01 Strict Target False Discovery Rate. Proteins were 357 
identified if minimum 2 unique peptide sequences more than 6 amino-acids passed the high confidence filter. 358 
Human keratin being considered as a common contaminant in protein identification by mass spectrometry, only 359 
hits with a number of PSM higher than keratin were considered significant. Mass spectrometry datasheets are 360 
available in Supplementary Datasheets 1-9. The experiments were done in triplicate and a representative result is 361 
shown. 362 
Cell fractionation 363 
Cell fractionation assay was performed as previously described15,23,25. Briefly, 5×1010 exponentially growing 364 
cells were resuspended in 750 μl of TSEN buffer and incubated for 10 min on ice. After addition of 100 μg.mL-1 365 
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of lysozyme and further incubation for 20 min on ice, 750 μL of TN buffer (Tris-HCl 10 mM, pH 8.0, NaCl 100 366 
mM) was added, and cells were lysed by three cycles of freezing and thawing and four cycles of sonication. 367 
Unbroken cells were removed by centrifugation, and soluble and membrane fractions were separated by 368 
ultracentrifugation for 45 min at 45,000×g. Membranes were washed once with TE buffer and resuspended in  1 369 
mL of TN buffer supplemented with 8 M urea, incubated on a wheel for 1 h at 25°C, and then centrifuged for 45 370 
min at 45,000×g to separate integral membrane and peripherally membrane associated proteins. Soluble and 371 
membrane-associated fractions were resuspended in loading buffer and subjected to SDS-PAGE and 372 
immunoblotting. Anti-EF-Tu (HyCult Biotech, clone mAb900), anti-VSV-G (Sigma-Aldrich, clone P5D4), anti-373 
OmpA, anti-TolA and anti-TolB (laboratory collection) antibodies were used to identify the cytoplasmic Tu 374 
elongation factor, the VSV-G-tagged TagA protein, the outer membrane OmpA protein, the inner membrane 375 
TolA protein, and the outer membrane-peripherally-associated periplasmic TolB protein, respectively. The 376 
experiments were done in triplicate and a representative result is shown. 377 
Bacterial two-hybrid assay (BACTH) 378 
The adenylate cyclase-based bacterial two-hybrid technique58 was used as previously published59. Briefly, the 379 
proteins to be tested were fused to the isolated T18 and T25 catalytic domains of the Bordetella adenylate 380 
cyclase. After introduction of the two plasmids producing the fusion proteins into the BTH101 reporter strain, 381 
plates were incubated at 30°C for 24 h. Three independent colonies for each transformation were inoculated into 382 
600 μL of LB medium supplemented with ampicillin, kanamycin, and IPTG (0.5 mM). After overnight growth at 383 
30°C, 10 μL of each culture was spotted onto LB plates supplemented with ampicillin, kanamycin, IPTG, and X-384 
gal and incubated at 30°C. Controls include interaction assays with TolB and Pal, two protein partners unrelated 385 
to the T6SS. The experiments were done in triplicate and a representative result is shown. 386 
Co-immuno-precipitation 387 
Soluble lysates from 2×1010 cells producing VSV-G-tagged TagA or VSV-G-tagged TagA and FLAG-tagged 388 
TssA were obtained using the cell fractionation procedure, and subjected to immuno-precipitation on anti-FLAG 389 
M2 affinity gel (Sigma-Aldrich) for 1 h at 20°C. Beads were washed three times with TN buffer, resuspended in 390 
non-reducing Laemmli loading dye, and subjected to SDS-PAGE and immuno-blot analyses using monoclonal 391 
anti-VSV-G (Sigma-Aldrich, clone P5D4) and anti-FLAG (Sigma-Aldrich, clone M2) antibodies. The 392 
experiments were done in triplicate and a representative result is shown. 393 
Inter-bacterial competition 394 
The anti-bacterial growth competition assay was performed as described60. The WT E. coli strain W3110 bearing 395 
the kanamycin resistant pUA66-rrnB plasmid61 was used as prey in the competition assay. The pUA66-rrnB 396 
plasmid provides a strong constitutive green fluorescent (GFP+) phenotype. Attacker and prey cells were grown 397 
in SIM medium to a A600nm ≈ 0.6-0.8, harvested and normalized to a A600nm of 10 in SIM. Attacker and prey cells 398 
were mixed to a 4:1 ratio and 15-μL drops of the mixture were spotted in triplicate onto a prewarmed dry SIM 399 
agar plate. After 4-hour incubation at 37°C, fluorescent images were recorded with a LI-COR Odyssey imager. 400 
The bacterial spots were scratched off, and cells were resuspended in LB medium and normalized to a A600nm of 401 
0.5. For fluorescence measurements, triplicates of 200 µl were transferred into wells of a black 96-well plate 402 
(Greiner) and the A600nm and fluorescence (excitation: 485 nm; emission: 530 nm) were measured with a TECAN 403 
infinite M200 microplate reader (9 measures per mixture per experiment). The relative fluorescence was 404 
expressed as the intensity of fluorescence divided by the A600nm, after subtracting the values of a blank sample. 405 
For enumeration of viable E. coli K-12 cells, serial dilutions were plated on kanamycin plates and the number of 406 
colonies were counted after 16-h incubation at 37°C. The experiments were done in triplicate and a 407 
representative result is shown. Statistical analyses of inter-bacterial competition assays were performed by 408 
Student's t-test. Significant differences were defined as p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***). 409 
Fluorescence microscopy. 410 
Cells were grown in SIM to a A600 nm ≈ 0.4–0.6, harvested and resuspended in fresh SIM to a A600 nm ≈ 10. Cell 411 
mixtures were spotted on a thin pad of SIM supplemented with 2% agarose, covered with a cover slip and 412 
incubated for 20-30 min at room temperature before microscopy acquisition. Fluorescence microscopy was 413 
performed with a Nikon Eclipse Ti microscope equipped with an Orcaflash 4.0 LT digital camera (Hamamatsu) 414 
and a perfect focus system (PFS) to automatically maintain focus so that the point of interest within a specimen 415 
is always kept in sharp focus at all times despite mechanical or thermal perturbations. All fluorescence images 416 
were acquired with a minimal exposure time to minimize bleaching and phototoxicity effects. Exposure times 417 
were typically 20 ms for phase contrast, 100 ms for TssB-GFP, 2000 ms for sfGFP-TagA and 800 ms for TssB-418 
mCherry and TssK-mCherry. The experiments were done in triplicate and a representative result is shown. For 419 
fluorescence microscopy, statistical analyses were performed using several representative fields from three 420 
independent biological replicates. Images were analyzed using ImageJ (http://imagej.nih.gov/ij/) and the 421 
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MicrobeJ plugin (http://www.microbej.com/)62 or Zen (Carl Zeiss). Statistical dataset analysis was performed 422 
using Excel and the R software environment (https://www.r-project.org/). Contractile sheath residence time was 423 
determined as the number of frames during which the sheath remained fully extended. Only sheaths that 424 
performed visible extension and contraction within the movie period were considered. 425 
Data availability. 426 
Excel sheets with the raw mass-spectrometry data are provided as Supplementary Datasheets 1-9. Plasmid 427 
pKD4-Nter-APEX2 has been deposited in the Addgene plasmid repository under accession number 112868. All 428 
data that support the findings of this study are available from the corresponding author upon request. 429 
 430 
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Legend to Figures 600 
Figure 1 | Summary of TssA proximity partners. The different stages of T6SS assembly 601 
are depicted (1, assembly of the membrane complex; 2, baseplate recruitment and docking; 3, 602 
polymerization of the tail), as well as the stage-blocking mutations used in this study (deletion 603 
of the tssK or vgrG gene stops T6SS assembly at stage 1 whereas deletion of the hcp gene 604 
stops T6SS assembly at stage 2). The TssA protein is shown in red and the other T6SS 605 
subunits are indicated (J corresponds to TssJ). The blue color highlights the subunits that are 606 
biotinylated by the functional APEX2-TssA fusion protein.  607 
Figure 2 | TagA is an accessory T6SS cytosolic component that associates with the 608 
membrane. a and b, TagA interacts directly with TssA. a, BACTH assay. BTH101 reporter 609 
cells producing the indicated proteins fused to the T18 and T25 domain of the Bordetella 610 
adenylate cyclase were spotted on X-Gal-IPTG reporter LB agar plates. The BACTH 611 
experiment was performed in triplicate with identical results. b, Co-immunoprecipitation 612 
assay. Soluble lysates of E. coli cells producing VSV-G-tagged TagA (VTagA) alone or 613 
VTagA with FLAG-tagged TssA (TssAF) were subjected to immunoprecipitation with anti-614 
FLAG-coupled beads. The total lysates (T) and immunoprecipitated (IP) material were 615 
separated by 12.5% acrylamide SDS-PAGE and immunodetected with anti-FLAG (upper 616 
panel) and anti-VSV-G (lower panel) monoclonal antibodies. Molecular weight markers (in 617 
kDa) are indicated on left. The co-immunoprecipitation experiment was performed in 618 
triplicate with identical results. c, TagA optimizes T6SS activity. Antibacterial competition 619 
assay. E. coli K-12 competitor cells (W3110 gfp+, kanR) were mixed with the indicated 620 
attacker cells, spotted onto SIM agar plates, and incubated for 4 h at 37 °C. The fluorescence 621 
of the bacterial spot (in arbitrary units, bars represent the average, standard deviation are 622 
indicated, dot plots (grey circles) are overlaid) is shown on top. The number of surviving E. 623 
coli competitor cells (counted on selective kanamycin medium) is indicated in the lower 624 
graph (in log10 of colony forming units). The circles indicate the values from three 625 
independent assays, and the average is indicated by the bar. Statistical significance relative to 626 
the wild-type strain is indicated (p-values; NS, non significant; *, p < 0.05; **, p < 0.01, two-627 
sided Student's t-test; p-values for fluorescence measurements (upper graph): ∆tssA, 628 
0.000196; ∆tagA, 0.0086; VtagA+, 0.119; tagA+, 0.746; p-values for E. coli K-12 survival 629 
(lower graph): ∆tssA, 0.00219; ∆tagA, 0.0194; VtagA+, 0.531; tagA+, 0.831). d, TagA 630 
fractionates with soluble and peripherally-associated membrane proteins. Fractionation assay. 631 
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Total extracts (T) of WT or ∆sci1 EAEC, or E. coli K-12 cells producing VTagA were 632 
subjected to fractionation to separate the soluble (S) and membrane (M) fractions. 633 
Peripherally-associated (pM) and integral (iM) membrane proteins were separated by 634 
treatment with 8 M urea. Control markers include the integral outer membrane OmpA protein, 635 
the integral inner membrane TolA protein, the peripherally-associated membrane TolB 636 
protein,  and the EF-Tu cytoplasmic elongation factor. Molecular weight markers (in kDa) are 637 
indicated on left. Fractionation experiments were performed in triplicate with identical results. 638 
Uncropped blots are shown in Supplementary Fig. 7. 639 
Figure 3 | TagA localizes at the cell quarters and binds the distal end of the sheath. a, 640 
Fluorescence microscopy recording of wild-type EAEC cells producing sfGFP-TagA (upper 641 
panel, phase channel; lower panel, GFP channel). Localization of TagA clusters are indicated 642 
by white arrowheads. Scale bar, 1 μm. Fluorescence microscopy recordings have been 643 
performed thirty times with identical results. A deconvolution analysis of WT EAEC cells 644 
producing sfGFP-TagA is shown in Supplementary Fig. 4a. b, Number of sfGFP-TagA foci 645 
per cell. The percentage of cells with 0, 1, 2 or >2 foci is indicated (n= 1171 cells from three 646 
biological replicates, bars represent the average, standard deviation are indicated, dot plots 647 
(grey circles) are overlaid). The mean number of foci per cell is 0.74 ± 0.24. c, Spatial 648 
repartition of sfGFP-TagA foci. Shown is a projection of the foci from n = 316 cells on a 649 
single cell (from blue (low abundance) to yellow (high abundance)). d, Fluorescence 650 
microscopy time-lapse recording of EAEC cells producing sfGFP-TagA. Individual images 651 
were taken every 40 s. The localization of TagA is indicated by the white arrowhead. A 652 
schematic diagram representating the dynamics of TagA is shown below. Scale bar, 1 μm. 653 
Time-lapse recordings have been performed thirty times with identical results. A statistical 654 
analyses of the distribution of sfGFP-TagA dynamics in wild-type and Δsci1 cells is shown in 655 
Supplementary Fig. 4b. e and f, Co-localization of sfGFP-TagA with TssB-mCherry (e) or 656 
TssK-mCherry (f). From top to bottom are shown the GFP, and mCherry channels, an overlay 657 
of the GFP and mCherry channels and a schematic representation. Scale bar, 1 μm. Statistical 658 
analyses of TagA co-localization with TssK and TssB are shown in Supplementary Figure 5. 659 
Co-localization recordings have been performed three and five times for TssK-mCherry and 660 
TssB-mCherry, respectively, with identical results. g, Fluorescence microscopy time-lapse 661 
recording of EAEC cells producing sfGFP-TagA and TssB-mCherry. Individual images were 662 
taken every 30 s. White arrowheads indicate assembly or contraction events whereas the blue 663 
arrowheads point at a complete assembly-contraction cycle. A schematic diagram 664 
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representating a complete cycle is shown below. Scale bar, 1 μm. See also Supplementary 665 
Video 1. Statistical analyses of co-localization of sfGFP-TagA with TssK-mCherry or with 666 
the distal end of the sheath are shown in Supplementary Fig. 5. Time-lipse co-localization 667 
recordings have been performed five times with identical results. 668 
Figure 4 | TagA stops sheath elongation and maintains the sheath under the extended 669 
conformation. a, Sheath dynamics. Fluorescence microscopy time-lapse recording of EAEC 670 
wild-type (WT), ΔtagA cells or ΔtagA cells expressing tagA (ΔtagA tagA+), producing TssB-671 
sfGFP. Individual images were taken every 40 s. White arrowheads indicate complete 672 
assembly-contraction cycles whereas blue arrowheads indicate sheaths that do not stop at the 673 
opposite membrane and bend. Red arrowheads point sheath detachment from the membrane 674 
complex/baseplate. Scale bar, 1 μm. See also Supplementary Video 2. Time-lapse recordings 675 
have been performed in triplicate with identical results. b, Quantification of the different 676 
sheath assembly events (blue, sheaths that stop at the opposite membrane; green, sheaths that 677 
do not stop at the opposite membrane, bend and break). The number of sheath events 678 
analyzed for each strain (n) is indicated on top, standard deviation are indicated by the vertical 679 
bar, dot plots (grey circles) are overlaid. c, Violin plot representation of the sheath residence 680 
time. The distribution of the sheath residence time in wild-type (WT, blue), ∆tagA (red) cells 681 
and ∆tagA expressing tagA (∆tagA tagA+, green) is represented as a violin plot. The bold 682 
horizontal bar represents the median values; the closed circle represents the mean: the lower 683 
and upper boundaries of the internal box plot correspond to the 25% and 75% percentiles 684 
respectively; the whiskers represent the 10% and 90% percentiles. Outliers are shown as black 685 
stars. The distribution is indicated by the outer shape. The number of sheath 686 
assembly/contraction events (n) is indicated on right, as well as the mean and the standard 687 
deviation, and the statistical significance relative to WT (NS, non significative; ****, p < 688 
0.0001; two-sided Wilcoxon’s t-test; p-values: ∆tagA, 2.2×10-16; tagA+, 0.62). The 689 
distribution is shown as a graph in Supplementary Fig. 6. 690 
Table 1. Mass spectrometry identification of proteins after APEX2-dependent proximity 
biotinylation.  
The highest ranked proteins are indicated, as well as the number of Peptide Spectral Matches 
(PSM), i.e., the number of validated peptides for the corresponding protein, indicating its 
relative abundance. The mass spectrometry datasheets are available in supplemental data files. 
 
 
APEX-TssAa APEX-TssAa,b nonec APEXd APEX-GspEe 
          
TssM 760 VgrG 405   AceF 120 GspL 377 
TssK 311 TssK 365     GspF 323 
VgrG 306 Hcp 349       
Hcp 258 TagA 234       
TssF 211 TssF 222       
TagA 193 TssC 87       
TssL 163 TssG 89       
TssG 64*         
TssC 54*         
 
 
a apex2 fused at the 5' of tssA. 
b no detergent used in the preparation of cell lysate. 
c no apex2 inserted on the chromosome. 
d apex2 inserted in the T6SS gene cluster. 
e apex2 fused at the 5' of gspE. 
* T6SS proteins with lower abundance than human keratin 
 
 
Table 2. Mass spectrometry identification of proteins after APEX2-dependent proximity 
biotinylation in stage-blocking mutant cells.  
The highest ranked proteins are indicated, as well as the number of Peptide Spectral Matches 
(PSM), i.e., the number of validated peptides for the corresponding protein, indicating its 
relative abundance. The mass spectrometry datasheets are available in supplemental data files. 
 
 
∆tssL ∆tssK ∆vgrG ∆hcp 
        
AceF 39 TssM 893 TssM 1343 TssM 1173 
  TssL 222 TssL 296 TssK 460 
  AceF 76 AceF 67 VgrG 448 
      TssF 241 
      TssL 235 
      TssG 102 
 
Figure 1!
M
L
K!
FG!
VgrG!
E
Hcp!
BC!
TagA!
1! 3!
ΔtssK!
ΔvgrG! Δhcp!2!
TssA!
J
Figure 2!
T18-Pal!
T18-TagA!
b!a!
c!
T! IP!T! IP!
TssAF 
VTagA !VTagA !
50!
64!
50!
64!
TssAF!
VTagA!
Re
lat
ive
 flu
or
es
ce
nc
e 
(1
04
 A
U)
!
1!
2!
3!
0!
NS!NS!**!**! d! iM!T! pM!M!S!
OmpA!36!
30!
VTagA!
36!
64!
50!
VTagA!
Δsci1!
36!
64!
50!
VTagA!
K-12!
36!
64!
50!
TolA!50!
64!
EF-Tu!
36!
50!
TolB!
36!
50!
NS!NS!*!**!8!
6!
5!
4!
7!
E.
 co
li K
-1
2 
su
rv
iva
l (
log
 cf
u)
!
WT! ∆tssA! ∆tagA! ∆tagA!
VtagA+!
∆tagA!
tagA+!
Figure 3!
c!a!
n=316!
40!0! 120!80!
d!
150! 180! 210! 240! 270!
0! 30! 60! 90! 120!
sfGFP-TagA / 
TssB-mCh!
extension! contraction!
sfGFP-TagA / 
TssK-mCh!
sfGFP-TagA / 
TssB-mCh!
g!f!e!
b!
80!
60!
40!
20!
> 2!0! 1!
foci per cell!
2!
%
 o
f c
ell
s!
0.74 ± 0.24!
n=1171!
Figure 4!
a!
c!
n=170!n=214! n=322!
ΔtagA  
tagA+!
WT! ΔtagA!
%
 o
f s
he
at
h 
as
se
m
bly
 e
ve
nt
s! 100
!
60!
40!
0!
20!
80!
sheath bending and breaking!
normal sheath extension!
0! 40! 80! 120! 160! 200!
240! 280! 320! 360! 400! 440!
TssB-sfGFP!
0! 40! 80! 120! 160! 200!
0! 40! 80! 120! 160! 200!
ΔtagA  
tagA+!
WT!
ΔtagA!
WT!
ΔtagA!
ΔtagA !
tagA+!
residence time (s)!
0! 100! 200! 1000!
0
300
600
900
A
B
C
Type
RT0
300
600
900
A
B
C
Type
RT0
300
600
900
A
B
C
Type
RT
0
300
600
900
A
B
C
Type
RT
500!
b!
476 s. ± 244!
449 s. ± 217!
162 s. ± 159!
NS!
n=111!
n=132!
n=62!
****!
